PaO
[용어속성] Term
Hyperimmune anti-COVID-19 IVIG (C-IVIG) Therapy for Passive Immunization of Severe and Critically Ill COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial
Letter
[키워드] 28-day mortality
accompany
acute lung injury
adverse event
airway
All participant
allergic
anti-COVID19 IVIG
Anti-viral
Antibiotics
assigned
assisted ventilation
autoimmune disorder
blinded
Blood oxygen saturation
blood pressure
C-IVIG
Care
Clinical efficacy
Comparator group
convalescent plasma
COVID-19
COVID19
criteria
Critically ill
Critically ill patient
CRP
current
disorder
dosage
Dyspnea
excluded
Follow-up
four group
group
hemodynamic
hemolytic anemia
hospital
hospital discharge
Hospital stay
hypersensitivity
ICU
IgA deficiency
Ill
immunization
Immunoglobulin
include
infected individual
Inflammation
information
inotropic agent
Intervention
intervention arm
Isolation
Karachi
kidney
Kidney failure
lung infiltrate
maintain
Manifestations
medication
Meningitis
MONITOR
multiple organ dysfunction
nasopharyngeal
neutrophil lymphocyte ratio
number
objective
observé
oropharyngeal swabs
outcome
PaO
parallel-group
participant
Passive
passive immunization
Patient
patients
positive SARS-CoV-2 PCR
pregnant females
Primary outcome
protocol
randomised
randomised controlled
randomised controlled trial
randomization
receive
recruited
Registered
reported
Respiratory failure
respiratory rate
Sample size
sealed
Septic shock
shifting
single dose
standard care
status
Steroids
Study protocol
Support
symptoms of COVID-19
therapy
thromboembolic
Total
Treatment
Trial
university
website
were excluded
with COVID-19
[DOI] 10.1186/s13063-020-04839-5 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04839-5 PMC 바로가기 [Article Type] Letter
Correlation between the variables collected at admission and progression to severe cases during hospitalization among patients with COVID-19 in Chongqing
Observational Study
[키워드] addition
Admission
alanine aminotransferase
Aspartate aminotransferase
AUC
Blood oxygen saturation
C-reactive protein
CD3
CD4 count
Chongqing
collected
coronavirus
COVID-19
creatinine
criteria
Critical
Critical care
D-dimer
demographics
disease
Dyspnea
enrolled
hospital
Hospitalization
Inflammation
interquartile
Laboratory test
median
Mild
mild case
moderate
PaO
Patient
patients with COVID-19
Platelet
Pneumonia
Potassium
predict
predictors
procalcitonin
progressed
progression
pulmonary
receiver operating characteristics
respiratory rate
Severe case
Severe patient
sodium
temperature
the patient
variable
with COVID-19
[DOI] 10.1002/jmv.26082 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1002/jmv.26082 PMC 바로가기 [Article Type] Observational Study
Effect of blood analysis and immune function on the prognosis of patients with COVID-19
Research Article
[키워드] added
Admission
Analysis
Area
baseline
Blood
CD3+
CD4+
cellular immune function
changes in
characteristic
COVID-19
death group
decrease
Effect
hemoglobin
hospitalized patient
IgA
IgE
IgG
IgM
immune function
implication
In-hospital death
investigated
leukocyte
lymphocyte
Lymphocyte count
Mortality
multivariate logistic regression
neutrophil
neutrophil count
non-survivor
not significant
outcome
PaO
parameter
Patient
patients died
Platelet
predict
Primary outcome
prognosis of patient
receive
Record
Result
Retrospective study
significantly
significantly higher
survival group
Survivors
with COVID-19
[DOI] 10.1371/journal.pone.0240751 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pone.0240751 PMC 바로가기 [Article Type] Research Article
Non‐invasive hemodynamic profile of early COVID‐19 infection
Original Research
[키워드] Acute respiratory failure
age
Cardiac index
characterized
Cohort
collected
COVID‐19
COVID‐19 infection
COVID‐19 patient
COVID‐19
CXR
early stage
echocardiographic
echocardiography
elevated
enrolled
Gas exchange
hemodynamic
Hemodynamics
hyperdynamic state
Hypoxemia
hypoxemic
initial
limits
mechanism
median
morphologically
oxygenation impairment
PaO
Patient
pulmonary
pulmonary artery pressure
resistance
Result
resulting
Sepsis
the disease
Total
TPR
variable
Vascular
vasoconstriction
[DOI] 10.14814/phy2.14628 PMC 바로가기 [Article Type] Original Research
[DOI] 10.14814/phy2.14628 PMC 바로가기 [Article Type] Original Research
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial
Letter
[키워드] 1:1
24 hour
Ability
absence
accompany
activity
Administered
administration
Admission
adverse events
Affect
age
alkaline phosphatase
allergy
ALT
alternative hypothesis
ambient
Analysis
ANC
Anti-inflammatory
anticipated
antipyretics
antivirals
Arm
ARMS
assumed
AST
Baltimore
baseline
benefit
blinded
block
block randomization
Blood
breastfeeding women
Bronchoalveolar lavage
calculated
Care
Cellulose
center
Chest
chest X-ray
childbearing potential
clinical
clinical condition
Clinical course
clinical impact
Clinical improvement
Clinical outcome
clinical status
clinical trial
collected
competing
Compliance
concealed
Concentration
Concomitant
conditions
conducted
congestive heart failure
Contraception
Control
control arm
Conventional
Corticosteroids
COVID-19
COVID-19 disease
COVID-19 infection
COVID-19 pandemic
criteria
criterion
Critical
CT scan
current
Day
Declaration of Helsinki
decrease
defined
detect
direct bilirubin
disease
disorder
dissemination
dose
double-blind
drug
Drug administration
drug-drug interaction
drugs
Duration
ECMO
Efficacy
Efficacy and safety
element
eligible
endosomal pH
Enrollment
ethnic group
evaluate
Evidence
exclusion
expected
exploratory endpoint
extracorporeal membrane oxygenation
Face mask
FDA
Fisher
Good
group
handling
harmonization
hematologic
histocompatibility complex
Hospitalization
Hospitalized
hospitalized patient
Hydroxychloroquine
Hypothesis
ICU
IL-6 levels
Imatinib
immunomodulatory
immunomodulatory drugs
IND
information
Informed consent
inhibitory activity
intensive care
intensive care unit
intention to treat
interfere
International Conference
invasive
Invasive mechanical ventilation
investigational agent
investigator
ITT
Laboratory
Last
limit
limitation
liver
Local
lysosomal sequestration
magnitude
matching placebo
mechanical ventilation
men and women
MHC
mononuclear cell
Mortality
nasal
nasopharyngeal
Nasopharyngeal swab
neutrophil count
New
new oxygen use
non-invasive ventilation
non-rebreather mask
not blinded
null hypothesis
number
objective
off-label
off-label use
Oropharyngeal
outcome
outcomes
oxygen
Oxygenation
P450
packaged
PaO
participant
Participants
Patient
patients
patients with ARDS
patients with COVID-19
PBMCs
performed
Pharmacist
Pharmacy
phase 3 study
Placebo
placebo-controlled
Pneumonia
positive COVID-19
Practice
primary analysis
primary endpoint
principal
progression
proportion
protocol
Psychiatric
Radiographic
random number generator
randomised controlled trial
randomization
Randomized
Randomized controlled trial
receive
receiving
recruitment
Regulatory
renal dysfunction
renal replacement therapy
replication of SARS-CoV-2
required
requiring supplemental oxygen
Respiratory illness
respiratory tract
risk
RT-PCR
Safety
Sample size
sarilumab
SARS-CoV
SARS-CoV-2
secondary endpoint
Seizure
Serious Adverse Events
service
severe disease
severity
significance level
Site
Society
stability
Standard of care
status
stratified
study drug
study enrollment
study outcomes
Study protocol
subject
submitted
supplemental oxygen
Support
Suspension
symptomatic
Tablet
temperature
Test
the patient
the primary endpoint
time
TKI
TKI-induced attenuation of vascular leak
TKI-induced prevention and treatment lung inflammation
Tocilizumab
transcriptomics
Treatment
treatment allocation
treatment arm
treatments for COVID-19
Trial
two-sided
tyrosine kinase inhibitor
uncontrolled
university
unstable angina
vasopressors
ventilator
ventilator free days
viral ABL-1 signalling
website
with COVID-19
[DOI] 10.1186/s13063-020-04819-9 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04819-9 PMC 바로가기 [Article Type] Letter
Factors influencing liberation from mechanical ventilation in coronavirus disease 2019: multicenter observational study in fifteen Italian ICUs
Research
[키워드] Admission
Analysis
analyzed
ARDS
cardiovascular complications
clinical
competing
complex
Compliance
Complication
contribute
coronavirus disease
Coronavirus disease 2019
Course
COVID-19
COVID-19 patient
death
demonstrated
develop
enrolled
Evolution
Factor
ICU
ICU admission
increasing age
independent risk factor
information
intensive care
Invasive mechanical ventilation
Italian
laboratory data
mechanical ventilation
Mortality
multicenter
multicenter observational study
multiple organ involvement
multivariate logistic regression
Non-pulmonary
observation period
Occurrence
organ dysfunction
outcome
Outcomes, mortality
PaO
Patient
patients with COVID-19
Pneumonia
primary outcome measure
proportion
prospective observational study
Regression model
renal
renal replacement therapy
Respiration, artificial
Respiratory system
Result
risk
risk factor
RRT
severe respiratory failure
SOFA score
the disease
the patient
VAP
variable
ventilator parameters
Ventilator-associated pneumonia
ventilator-free day
were recorded
[DOI] 10.1186/s40560-020-00499-4 PMC 바로가기 [Article Type] Research
[DOI] 10.1186/s40560-020-00499-4 PMC 바로가기 [Article Type] Research
Residual clinical damage after COVID-19: A retrospective and prospective observational cohort study
Research Article
[키워드] 95% CI
95% confidence interval
age
Analysis
benefit
blood pressure
BMI
body mass index
Cognitive impairment
COVID-19
defined
Department
diabete
disorder
dysfunction
Dyspnoea
Emergency
enrolled
evaluated
female gender
Follow-up
fractional inspired oxygen
highest
hospital discharge
hospitalisation
Hospitalised patients
identify
independent predictor
Malnutrition
moderate
non-invasive ventilation
Odds ratio
outcome
oxygen
PaO
Patient
patients
physical
predicted
Probability
prospective observational cohort
Protective
Psychological
PTSD
residual
respiratory rate
retrospective
risk
secondary outcome
selected
Stress
tachypnoeic
therapeutic
[DOI] 10.1371/journal.pone.0239570 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pone.0239570 PMC 바로가기 [Article Type] Research Article
Comparison of Efficacy of Dexamethasone and Methylprednisolone in Improving PaO2/FiO2 Ratio Among COVID-19 Patients
Internal Medicine
[키워드] acute respiratory syndrome
administration
anti-inflammatory treatment
Antiviral
C-reactive protein
calculated
Clinicians
coronavirus
coronavirus disease
covid induced ards
COVID-19
COVID-19 patients
CRP
cytokines release syndrome
Dexamethasone
distress
drug
effective
Effectiveness
eight
global pandemic
group
Host
immune reaction
Improving
inflammation markers
inflammatory markers
initial
less
Methylprednisolone
Oxygenation
P/F
P/F ratio
PaO
paO2/fiO2
participant
Participants
Patient
Ratio
ratio of partial pressure of arterial oxygen and fraction of inspired oxygen
recorded
reduced
Result
retrospective
SARS-CoV-2
serum ferritin level
significantly
steroid therapy
Study design
syndrome
t-test
two group
viral replication
was used
Wuhan, China
[DOI] 10.7759/cureus.10918 PMC 바로가기 [Article Type] Internal Medicine
[DOI] 10.7759/cureus.10918 PMC 바로가기 [Article Type] Internal Medicine
Therapeutic effects of adenosine in high flow 21% oxygen aereosol in patients with Covid19-pneumonia
코비드19-폐렴 환자의 고유량 21% 산소 에어로졸에서 아데노신의 치료 효과
Research Article
[키워드] 24 hour
24 hours
active treatments
adenosine
agonist
Analysis
ARDS
bronchospasm
change
clinical trials
control group
controlled clinical trials
death
demonstrated
Effect
enrolled
experimental group
feature
hemodynamic
historical control
Hospitalized
Infection
Inflammatory
inflammatory lung disease
Inhaled
interstitial
lack
lung
Lung disease
Lung inflammation
mice
Mitigation
moderate
outcome
oxygen
oxygenated
PaO
Patient
patients treated
preclinical studies
preclinical study
radiological
receive
receiving
receptor
recorded
reported
Result
SARS-CoV-2 RNA
SARS-CoV2 infection
severe lung inflammation
severity
significant increase
syndrome
the disease
therapeutic effect
Treatment
Trigger
Ventilation
were recorded
[DOI] 10.1371/journal.pone.0239692 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pone.0239692 PMC 바로가기 [Article Type] Research Article